SIM
CSBR icon

Spark Investment Management’s Champions Oncology CSBR Stock Holding History

Spark Investment Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,598
Closed -$82K – 714
2017
Q3 		$82K Sell
22,598
-17,602
-44% -$53.9K ﹤0.01% 672
2017
Q2 		$103K Hold
40,200
– – 0.01% 717
2017
Q1 		$127K Buy
+40,200
New +$141K 0.01% 753

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Spark Investment Management's CSBR Position: Q4 2017 in Review

Spark Investment Management sold out of Champions Oncology (CSBR) in Q4 2017, closing a stake of 22,598 shares — an estimated $82K sold.

Spark Investment Management first reported a position in CSBR in Q1 2017 and held it in 3 quarters. The position peaked at $127K in Q1 2017. 14 funds tracked by Wall St. Rank hold CSBR as of Q4 2017.

  • Spark Investment Management reported no remaining Champions Oncology position as of Q4 2017 after selling out during the quarter.
  • Spark Investment Management sold 22,598 Champions Oncology shares in Q4 2017, an estimated $82K.
  • Spark Investment Management first reported a position in Champions Oncology in Q1 2017 and held it in 3 quarters.
  • Spark Investment Management's Champions Oncology position peaked at $127K in Q1 2017.
  • 14 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2017.

Based on Spark Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.